In 2008, Addario Lung Cancer Medical Institute was founded  as a 501c(3) non-profit organization, is a patient-centric, international research consortium driving research otherwise not feasible.

ALCMI overcomes barriers to collaboration via a world-class team of investigators from more than 25 institutions in the United States, France, Italy, Spain and United Kingdom, supported by dedicated research infrastructures such as centralized tissue banks and data systems.